Lptx stock earnings

Mar 30, 2020 · View today's stock price, news and analysis for Leap Therapeutics Inc. (LPTX). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and LPTX Stock Price and Chart — NASDAQ:LPTX — TradingView — … TradingView India. View live LEAP THERAPEUTICS INC chart to track its stock's price action. Find market predictions, LPTX financials and market news.

Get the latest Leap Therapeutics, Inc. LPTX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Leap Therapeutics, Inc. - LPTX - Stock Price Today - Zacks LPTX is up 2.16% today, Stock Earnings - research.tdameritrade.com TD Ameritrade displays two types of stock earnings numbers, which are calculated differently and may report different values for the same period. GAAP earnings are the official numbers reported by a company, and non-GAAP earnings are adjusted to be more readable in earnings history and forecasts. LPTX's fiscal year ends in December. Market LPTX | Stock Snapshot - Fidelity Apr 03, 2020 · Stock quote and company snapshot for LEAP THERAPEUTICS INC (LPTX), including profile, stock chart, recent news and events, analyst opinions, and research reports. LPTX | Stock Snapshot - Fidelity Skip to Main Content. Leap Therapeutics, Inc. (LPTX) Analyst Ratings, Estimates ... See Leap Therapeutics, Inc. (LPTX) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.

LPTX's NASDAQ Last Sale (NLS) "Last Sale" is the price at which a stock last traded during regular market hours. NLS Volume "Volume" is the number of shares of the stock traded on the listing exchange during regular trading hours. Previous Close Today's High / Low 52 Week High / Low

LPTX | Leap Therapeutics Inc. Analyst Estimates & Rating – WSJ Leap Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. LPTX updated stock price target summary. Leap Therapeutics (NasdaqGM:LPTX) - Share price, News ... Earnings vs Industry: LPTX is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (22%). Return on Equity High ROE : LPTX's liabilities exceed its assets, so it is difficult to calculate its Return on Equity . A look at earnings from the view of ... - Earnings Whispers A look at earnings from the view of macro-economists and market technicians. Market Overview. Heat Map. Sentiment. Technicals. Retail Sales. Pricing. Manu-facturing. Economic Cycle. Bottom-up. A bottom-up view of earnings from professional equity analysts. Earnings Highlights. Date Trades. Earnings News. Pivots. Earnings Cycle. Sector Analysis.

Leap Therapeutics, Inc. (LPTX) Stock Analysis & News ...

Earnings vs Industry: LPTX is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (22%). Return on Equity High ROE : LPTX's liabilities exceed its assets, so it is difficult to calculate its Return on Equity . A look at earnings from the view of ... - Earnings Whispers A look at earnings from the view of macro-economists and market technicians. Market Overview. Heat Map. Sentiment. Technicals. Retail Sales. Pricing. Manu-facturing. Economic Cycle. Bottom-up. A bottom-up view of earnings from professional equity analysts. Earnings Highlights. Date Trades. Earnings News. Pivots. Earnings Cycle. Sector Analysis.

Leap Therapeutics, Inc. (LPTX) latest earnings report: revenue, EPS, surprise, history, news and analysis.

LPTX Stock Price and Chart — NASDAQ:LPTX — TradingView Leap Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel therapies designed to treat patients with cancer. Its clinical stage programs are DKN-01, which is a monoclonal antibody that inhibits Dickkopf-related protein 1, or DKK1 and TRX518, which is a monoclonal antibody targeting the Investors | Leap Therapeutics, Inc. The Investor Relations website contains information about Leap Therapeutics, Inc.'s business for stockholders, potential investors, and financial analysts.

Apr 03, 2020 · Stock quote and company snapshot for LEAP THERAPEUTICS INC (LPTX), including profile, stock chart, recent news and events, analyst opinions, and research reports. LPTX | Stock Snapshot - Fidelity Skip to Main Content.

LPTX: Leap Therapeutics, Inc. - Earnings News & Analysis ... LPTX: Leap Therapeutics, Inc. - Earnings Announcements. Stay up to date with lastest Earnings Announcements for Leap Therapeutics, Inc. from Zacks Investment Research LPTX:NASDAQ GM Stock Quote - Leap Therapeutics Inc ... Stock analysis for Leap Therapeutics Inc (LPTX:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. LPTX | Leap Therapeutics Inc. Stock Price & News - WSJ

In depth view into LPTX (Leap Therapeutics) stock including the latest price, news, dividend history, earnings information and financials. $LPTX Stock Technical Analysis | LEAP | SwingTradeBot.com Sep 27, 2019 · LPTX closed up 2.6 percent on Tuesday, March 31, 2020, on 16 percent of normal volume. The stock crossed above its 200 day moving average, improving its long-term outlook by crossing above that critical trendline. LPTX Stock Rating and Data | Leap Therapeutics - GuruFocus.com LPTX stock rating and analysis - Leap Therapeutics : a summary of key financial strength and profitability metrics. Home Homepage Membership Levels Membership Data Coverage Complete Stock List Founder's Message The book Value Investing Forum Podcast Free Trial Earnings Whisper Number for BTAI: Bioxcel Therapeutics